Scabies: More than just an irritation

Postgraduate Medical Journal

Volumn 80, Issue 945, 2004, Pages 382-387

  McCarthy, J S ^a,b   Kemp, D J ^a,b,c,d   Walton, S F ^c,d   Currie, B J ^c,e  

^a QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

^c MENZIES SCHOOL OF HEALTH RESEARCH   (Australia)

^d Co Oper Res Ctr Far Aboriginal H ^*  (Australia)

^e FLINDERS UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

VACCINE;

ANTIBIOTIC RESISTANCE; CLINICAL FEATURE; CROWDING; ENDEMIC DISEASE; EPIDEMIC; GLOMERULONEPHRITIS; HEALTH CARE POLICY; HUMAN; HYGIENE; MORBIDITY; NONHUMAN; POVERTY; PRURITUS; REVIEW; SARCOPTES SCABIEI; SCABIES; SEPSIS; VACCINATION;

ANIMAL DISEASES; ANIMALS; CROWDING; DISEASE OUTBREAKS; HUMANS; HYGIENE; POVERTY; RECURRENCE; SCABIES;

EID: 3242708520     PISSN: 00325473     EISSN: None     Source Type: Journal    
DOI: 10.1136/pgmj.2003.014563     Document Type: Review

References (51)

1. Taplin D, Meinking TL, Chen JA, et al. Comparison of crotamiton 10% cream (Eurax) and permethrin 5% cream (Elimite) for the treatment of scabies in children. Pediatr Dermatol 1990;7:67-73.
2. Alexander JO. Scabies. Arthropods and human skin. New York: Springer-Verlag, 1984:227-92.
3. Mellanby K. Scabies in 1976. Royal Society of Health Journal 1977;97:32-6, 40.
4. Stromberg PC, Fisher WF. Dermatopathology and immunity in experimental Psoroptes ovis (Acari: Psoroptidae) infestation of naive and previously exposed Hereford cattle. Am J Vet Res 1986;47:1551-60.
5. Pettit D, Smith WD, Richardson J, et al. Localisation and characterisation of ovine immunglobulin within the sheep scab mite, Psoroptes ovis. Vet Parasitol 2000;89:231-9.
6. Arlian LG, Vyszenski-Moher DL, Pole MJ. Survival of adults and development stages of Sarcoptes scabiei var canis when off the host. Exp Appl Acarol 1989;6:181-7.
7. Mellanby K. The development of symptoms, parasitic infection and immunity in human scabies. Parasitology 1944;35:197-206.
8. Danielssen DC, Boeck W. Traite de la Spedalsked ou Elephantiasis des Grecs. Paris: J B Balliere, 1848.
9. Currie BJ, Maguire GP, Wood YK. Ivermectin and crusted (Norwegian) scabies. Med J Aust 1995;163:559-60.
10. Gogna NK, Lee KC, Howe DW. Norwegian scabies in Australian Aborigines. Med J Aust 1985;142:140-2.
11. Van Neste D, Lachapelle JM. Host-parasite relationships in hyperkeratotic (Norwegian) scabies: pathological and immunological findings. Br J Dermatol 1981;105:667-78.
12. Huffam SE, Currie BJ. Ivermectin for Sarcoptes scabiei hyperinfestation. Int J Infect Dis 1998;2:152-4.
13. Hulbert TV, Larsen RA. Hyperkeratotic (Norwegian) scabies with gram-negative bacteremia as the initial presentation of AIDS. Clin Infect Dis 1992;14:1164-5.
14. Currie BJ, Carapetis JR. Skin infections and infestations in Aboriginal communities in northern Australia. Australas J Dermatol 2000;41:139-43.
15. Svartman M, Finklea JF, Earle DP, et al. Epidemic scabies and acute glomerulonephritis in Trinidad. Lancet 1972;i:249-51.
16. Hersch C. Acute glomerulonephritis due to skin disease, with special reference to scabies. S Afr Med J 1967;41:29-34.
17. Carapetis JR, Connors C, Yarmirr D, et al. Success of a scabies control program in an Australian aboriginal community. Pediatr Infect Dis J 1997;16:494-9.
18. Taplin D, Porcelain SL, Meinking TL, et al. Community control of scabies: a model based on use of permethrin cream. Lancet 1991;337:1016-8.
19. Walton SF, Myerscough MR, Currie BJ. Studies in vitro on the relative efficacy of current acaricides for Sarcoptes scabiei var hominis. Trans R Soc Trop Med Hyg 2000;94:92-6.
20. Hogan DJ, Schachner L, Tanglertsampan C. Diagnosis and treatment of childhood scabies and pediculosis. Pediatr Clin North Am 1991;38:941-57.
21. Walker GJ, Johnstone PW. Interventions for treating scabies. Cochrane Database Syst Rev 2000;(3):CD000320.
22. Friedman SJ. Lindane neurotoxic reaction in nonbullous congenital ichthyosiform erythroderma. Arch Dermatol 1987;123:1056-8.
23. Elgart ML. A risk-benefit assessment of agents used in the treatment of scabies. Drug Saf 1996;14:386-93.
24. Roos TC, Alam M, Roos S, et al. Pharmacotherapy of ectoparasitic infections. Drugs 2001;61:1067-88.
25. Rauch AE, Kowalsky SF, Lesar TS, et al. Lindane (Kwell)-induced aplastic anemia. Arch Intern Med 1990;150:2393-5.
26. Parent-Massin D, Thouvenot D, Rio B, et al. Lindane haematotoxicity confirmed by in vitro tests on human and rat progenitors. Hum Exp Toxicol 1994;13:103-6.
27. Albahary C, Dubrisay J, Guerin. Obstinate pancytopenia due to lindane (gamma isomer of hexachlorocyclohexane). Arch Mal Prof 1957;18:687-91.
28. Elmogy M, Fayed H, Marzok H, et al. Oral ivermectin in the treatment of scabies. Int J Dermatol 1999;38:926-8.
29. Meinking TL, Taplin D, Hermida JL, et al. The treatment of scabies with ivermectin. N Engl J Med 1995;333:26-30.
30. Barkwell R, Shields S. Deaths associated with ivermectin treatment of scabies. Lancet 1997;349:1144-5.
31. Coyne PE, Addiss DG. Deaths associated with ivermectin for scabies. Lancet 1997;350:215-6; author reply 216.
32. Reintjes R, Hoek C. Deaths associated with ivermectin for scabies. Lancet 1997;350:215; author reply 216.
33. Boix V, Sanchez-Paya J, Portilla J, et al. Nosocomial outbreak of scabies clinically resistant to lindane. Infect Control Hosp Epidemiol 1997;18:677.
34. Currie BJ, Harumal P, McKinnon M, et al. First documentation of in vivo and in vitro ivermectin resistance in Sarcoptes scabiei. Clin Infect Dis 2004 (in press).
35. Walton SF, McBroom J, Mathews J, et al. Crusted scabies: a molecular analysis of Sarcoptes scabiei var hominis populations in patients with repeated infestations. Clin Infect Dis 1999;29:1226-30.
36. Anonymous. Scabies in health-care facilities - Iowa. MMWR Morb Mortal Wkly Rep 1988;37(11):178-9.
37. Degelau J. Scabies in long-term care facilities. Infect Control Hosp Epidemiol 1992;13:421-5.
38. Sullivan JR, Watt G, Barker B. Successful use of ivermectin in the treatment of endemic scabies in a nursing home. Australas J Dermatol 1997;38:137-40.
39. Currie BJ, Connors CM, Krause VL. Scabies programs in aboriginal communities. Med J Aust 1994;161:636-7.
40. Nair BK, Joseph A, Kandamuthan M. Epidemic scabies. Indian J Med Res 1977;65:513-8.
41. Orkin M. Resurgence of scabies. JAMA 1971;217:593-7.
42. Taplin D, Rivera A, Walker JG, et al. A comparative trial of three treatment schedules for the eradication of scabies. J Am Acad Dermatol 1983;9:550-4.
43. Wong LC, Amega B, Connors C, et al. Outcome of an interventional program for scabies in an Indigenous community. Med J Aust 2001;175:367-70.
44. Pence D, Ueckermann E. Sarcoptic mange in wildlife. Rev Sci Tech 2002;21:385-98.
45. Cargill CF, Pointon AM, Davies PR, et al. Using slaughter inspections to evaluate sarcoptic mange infestation of finishing swine. Vet Parasitol 1997;70(1-3):191-200.
46. Davis DP, Moon RD. Dynamics of swine mange: a critical review of the literature. J Med Entomol 1990;27:727-37.
47. Arlian LG. Biology, host relations, and epidemiology of Sarcoptes scabiei. Annu Rev Entomol 1989;34:139-61.
48. Arlian LG, Morgan MS, Vyszenski-Moher DL, et al. Sarcoptes scabiei: the circulating antibody response and induced immunity to scabies. Exp Parasitol 1994;78:37-50.
49. Arlian LG, Rapp CM, Morgan MS. Resistance and immune response in scabies-infested hosts immunized with Dermatophagoides mites. Am J Trop Med Hyg 1995;52:539-45.
50. Willadssn P. Novel vaccines for ectoparasites. Vet Parasitol 1997;71(2-3):209-22.
51. Boue O, Redondo M, Montero C, et al. Reproductive and safety assessment of vaccination with Gavac against the cattle tick (Boophilus microplus). Theriogenology 1999;51:1547-54.